A detailed history of American Portfolios Advisors transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,150 shares of ADVM stock, worth $7,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,150
Holding current value
$7,026
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$0.96 - $9.68 $1,104 - $11,132
1,150 New
1,150 $1.09 Million
Q2 2022

Mar 20, 2023

BUY
$0.81 - $1.34 $44,550 - $73,700
55,000 Added 4782.61%
56,150 $67.4 Million
Q1 2022

Mar 21, 2023

BUY
$1.23 - $1.95 $30,750 - $48,750
25,000 Added 2173.91%
26,150 $34.3 Million
Q4 2021

Mar 21, 2023

BUY
$1.74 - $2.4 $8,700 - $12,000
5,000 Added 434.78%
6,150 $10.8 Million
Q3 2021

Mar 22, 2023

BUY
$2.08 - $3.6 $832 - $1,440
400 Added 34.78%
1,550 $3.36 Million
Q2 2021

Mar 22, 2023

BUY
$3.36 - $10.56 $1,344 - $4,224
400 Added 34.78%
1,550 $5.43 Million
Q1 2021

Mar 22, 2023

BUY
$9.26 - $14.36 $2,315 - $3,590
250 Added 21.74%
1,400 $13.8 Million
Q4 2020

Mar 22, 2023

BUY
$9.84 - $14.26 $3,936 - $5,704
400 Added 34.78%
1,550 $16.8 Million
Q3 2020

Mar 22, 2023

BUY
$10.3 - $21.64 $4,120 - $8,656
400 Added 34.78%
1,550 $16 Million
Q1 2020

Mar 24, 2023

SELL
$7.98 - $16.32 $7,581 - $15,504
-950 Reduced 82.61%
200 $1.95 Million
Q4 2019

Mar 24, 2023

SELL
$5.12 - $12.22 $4,864 - $11,609
-950 Reduced 82.61%
200 $2.3 Million
Q2 2019

Mar 24, 2023

SELL
$5.1 - $11.89 $4,845 - $11,295
-950 Reduced 82.61%
200 $2.38 Million

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $607M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.